文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Pharmacovigilance in the Community: A Special-Interest Group of the International Society of Pharmacovigilance.

作者信息

Elhawary Mohamed A, Noss Rebecca, Alj Loubna, Younus Manal, Alkhakany Mayada, Rostom Hadir, Caro-Rojas Angela, Alshammari Thamir M

机构信息

Egyptian Ministry of Health and Population, Expanded Programme on Immunization (General Secretary of ISoP Egypt Chapter), Cairo, Egypt.

Faculty of Pharmacy, Ain Shams University, Cairo, Egypt.

出版信息

Drug Saf. 2025 Mar;48(3):203-207. doi: 10.1007/s40264-024-01513-6. Epub 2025 Jan 8.

DOI:10.1007/s40264-024-01513-6
PMID:39779631
Abstract
摘要

相似文献

[1]
Pharmacovigilance in the Community: A Special-Interest Group of the International Society of Pharmacovigilance.

Drug Saf. 2025-3

[2]
The International Society of Pharmacovigilance (ISoP) Pharmacogenomic Special Interest Group: Pharmacogenomics in Pharmacovigilance.

Drug Saf. 2021-6

[3]
Medication Errors Special Interest Group of the International Society of Pharmacovigilance and the Trends in International Collaboration for Patient Safety.

Drug Saf. 2022-2

[4]
The International Society of Pharmacovigilance (ISoP) Special Interest Group on Herbal and Traditional Medicines: Towards Progress in Pharmacovigilance for Herbal and Traditional Medicines and Other "Natural Health" Products.

Drug Saf. 2020-7

[5]
The International Society of Pharmacovigilance Vaccines Special Interest Group: Challenges and Opportunities.

Drug Saf. 2022-6

[6]
Communicating for the Safe Use of Medicines: Progress and Directions for the 2020s Promoted by the Special Interest Group of the International Society of Pharmacovigilance.

Drug Saf. 2023-6

[7]
A Framework for Promoting Safety Monitoring of Herbal Medicines: The International Society of Pharmacovigilance Special Interest Group on Herbal and Traditional Medicines.

Drug Saf. 2024-6

[8]
The ISoP CommSIG for Improving Medicinal Product Risk Communication: A New Special Interest Group of the International Society of Pharmacovigilance.

Drug Saf. 2015-7

[9]
Developing a Crowdsourcing Approach and Tool for Pharmacovigilance Education Material Delivery.

Drug Saf. 2017-3

[10]
Safety of a fixed-dose combination of artesunate and amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in real-life conditions of use in Côte d'Ivoire.

Malar J. 2017-1-3

本文引用的文献

[1]
A Framework for Promoting Safety Monitoring of Herbal Medicines: The International Society of Pharmacovigilance Special Interest Group on Herbal and Traditional Medicines.

Drug Saf. 2024-6

[2]
Appeal for Increasing the Impact of Pharmacovigilance.

Drug Saf. 2024-2

[3]
The Role of ISoP in the Advancement of Pharmacovigilance in Low-and Middle-Income Countries (LMICs).

Drug Saf. 2023-12

[4]
Sharing Adverse Drug Event Reports Between Hospitals and Community Pharmacists to Inform Re-dispensing: An Analysis of Reports and Process Outcomes.

Drug Saf. 2023-11

[5]
Enhancing self-medication practices in the era of infodemic: the role of pharmacovigilance.

Ther Adv Drug Saf. 2023-8-23

[6]
The ISoP PatEG-SIG for Promoting Patient Engagement in Pharmacovigilance: A Change of Paradigm is Needed.

Drug Saf. 2023-7

[7]
Defining and enhancing collaboration between community pharmacists and primary care providers to improve medication safety.

Expert Opin Drug Saf. 2022-11

[8]
Medication Errors Special Interest Group of the International Society of Pharmacovigilance and the Trends in International Collaboration for Patient Safety.

Drug Saf. 2022-2

[9]
A Multidisciplinary Approach in Pharmacovigilance Awareness: ISoP Egypt Chapter's MedSafetyWeek Experience.

Drug Saf. 2021-10

[10]
Patient safety management systems and activities related to promoting voluntary in-hospital reporting and mandatory national-level reporting for patient safety issues: A cross-sectional study.

PLoS One. 2021

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索